Viscosupplementation - Medical Devices Pipeline Assessment, 2016

  • ID: 3942702
  • Report
  • 64 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Bioventus LLC
  • Chi2Gel Ltd.
  • DePuy Synthes, Inc.
  • Maxigen Biotech Inc.
  • Spring Therapeutics
  • MORE
Viscosupplementation - Medical Devices Pipeline Assessment, 2016

Summary

Our Medical Devices sector report, “Viscosupplementation - Medical Devices Pipeline Assessment, 2016" provides an overview of Viscosupplementation currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Viscosupplementation pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by our team of industry experts.

- Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Viscosupplementation under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Viscosupplementation and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Viscosupplementation under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Bioventus LLC
  • Chi2Gel Ltd.
  • DePuy Synthes, Inc.
  • Maxigen Biotech Inc.
  • Spring Therapeutics
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Viscosupplementation Overview

3 Products under Development

3.1 Viscosupplementation - Pipeline Products by Stage of Development

3.2 Viscosupplementation - Pipeline Products by Segment

3.3 Viscosupplementation - Pipeline Products by Territory

3.4 Viscosupplementation - Pipeline Products by Regulatory Path

3.5 Viscosupplementation - Pipeline Products by Estimated Approval Date

3.6 Viscosupplementation - Ongoing Clinical Trials

4 Viscosupplementation - Pipeline Products under Development by Companies

4.1 Viscosupplementation Companies - Pipeline Products by Stage of Development

4.2 Viscosupplementation - Pipeline Products by Stage of Development

5 Viscosupplementation Companies and Product Overview

5.1 Anika Therapeutics, Inc. Company Overview

5.1.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.2 BioPolymer GmbH & Co. KG Company Overview

5.2.1 BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview

5.3 Bioventus LLC Company Overview

5.3.1 Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview

5.4 Carbylan Therapeutics, Inc. Company Overview

5.4.1 Carbylan Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.5 Carticept Medical, Inc. Company Overview

5.5.1 Carticept Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.6 Chi2Gel Ltd. Company Overview

5.6.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.7 Cocoon Biotech, Inc. Company Overview

5.7.1 Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.8 DePuy Synthes, Inc. Company Overview

5.8.1 DePuy Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.9 Flex Biomedical, Inc. Company Overview

5.9.1 Flex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.10 Hanmi Pharmaceuticals, Co. Ltd. Company Overview

5.10.1 Hanmi Pharmaceuticals, Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.11 Maxigen Biotech Inc. Company Overview

5.11.1 Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.12 Moebius Medical Ltd. Company Overview

5.12.1 Moebius Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.13 Shanghai Haohai Biological Technology Co., Ltd. Company Overview

5.13.1 Shanghai Haohai Biological Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.14 Spring Therapeutics Company Overview

5.14.1 Spring Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

5.15 Synolyne Pharma Company Overview

5.15.1 Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview

5.16 University of Kansas Company Overview

5.16.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

6 Viscosupplementation- Recent Developments

6.1 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results

6.2 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results

6.3 Jul 19, 2016: Bioventus Withdraws IPO

6.4 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017

6.5 Jul 05, 2016: Fidia Presents New Data on Hymovis, a Breakthrough in Viscoelastic Technology, at the American Orthopaedic Society for Sports Medicine 2016 Annual Meeting

6.6 Jul 01, 2016: Bioventus Extends Distribution Agreement for SUPARTZ FX

6.7 Jun 24, 2016: Michael Minogue Named to Bioventus Board of Managers

6.8 Jun 01, 2016: Anika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis

6.9 May 31, 2016: Fidia Announces US Commercial Availability of Hymovis, a Next-Generation Hyaluronan

6.10 May 19, 2016: Pendopharm Announces Canadian Launch Of Cingal In Partnership With Anika Therapeutics

6.11 Apr 27, 2016: Anika Reports First Quarter 2016 Financial Results

6.12 Apr 04, 2016: Anika Appoints New Chief Medical Officer and Chief Operations Officer

6.13 Mar 28, 2016: Anika Therapeutics Wins CE Mark Approval For Cingal For The Treatment Of Pain Associated With Osteoarthritis Of The Knee

6.14 Mar 08, 2016: Peter Mitchell Named Chief Scientific Officer At Cocoon Biotech

6.15 Feb 25, 2016: Fidia Introduces Hymovis, a Next-Generation Hyaluronan, at the AAOS Annual Meeting in Orlando

6.16 Feb 24, 2016: Anika Therapeutics Delivers Strong Performance with Record Product Revenue for the Fourth Quarter and Full Year 2015

6.17 Jan 22, 2016: BONESUPPORT Announces Appointment Of Life Sciences Industry Veteran, Richard Davies, As New Chief Executive Officer

6.18 Dec 09, 2015: Anika Therapeutics Announces Decision to Proceed with CINGAL Premarket Review Through FDA's Center for Drug Evaluation and Research

6.19 Dec 01, 2015: Zimmer Biomet Announces Expanded FDA Safety Claim for Gel-One Cross-Linked Hyaluronate

6.20 Nov 03, 2015: Anika Therapeutics Announces Health Canada Approval of CINGAL for the Treatment of Pain Associated with Osteoarthritis of the Knee

6.21 Nov 02, 2015: Fidia Presents Hymovis, a New Generation Hyaluronan, at the ACR Annual Meeting in San Francisco

6.22 Nov 02, 2015: Fidia Presents Hymovis, a New Generation Hyaluronan, at the ACR Annual Meeting in San Francisco

6.23 Oct 29, 2015: Anika Appoints Richard Hague to Role of Chief Commercial Officer

6.24 Oct 28, 2015: Anika Therapeutics Reports Robust Financial Performance and Continued Progress on Key Fronts in Third Quarter of 2015

7 Appendix

7.1 Methodology

7.2 About us

7.3 Contact Us

7.4 Disclaimer

1.1 List of Tables

Table 1: Viscosupplementation - Pipeline Products by Stage of Development

Table 2: Viscosupplementation - Pipeline Products by Segment

Table 3: Viscosupplementation - Pipeline Products by Territory

Table 4: Viscosupplementation - Pipeline Products by Regulatory Path

Table 5: Viscosupplementation - Pipeline Products by Estimated Approval Date

Table 6: Viscosupplementation - Ongoing Clinical Trials

Table 7: Viscosupplementation Companies - Pipeline Products by Stage of Development

Table 8: Viscosupplementation - Pipeline Products by Stage of Development

Table 9: Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 10: Cingal - Product Status

Table 11: Cingal - Product Description

Table 12: MONOVISC - Product Status

Table 13: MONOVISC - Product Description

Table 14: MONOVISC - Hip - Product Status

Table 15: MONOVISC - Hip - Product Description

Table 16: Anika Therapeutics, Inc. - Ongoing Clinical Trials Overview

Table 17: MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip

Table 18: BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview

Table 19: Crespine Gel - Product Status

Table 20: Crespine Gel - Product Description

Table 21: Crespine Gel Plus - Product Status

Table 22: Crespine Gel Plus - Product Description

Table 23: Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview

Table 24: Supartz 3 - Product Status

Table 25: Supartz 3 - Product Description

Table 26: Carbylan Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 27: ActaVisc - Product Status

Table 28: ActaVisc - Product Description

Table 29: Hydros - Product Status

Table 30: Hydros - Product Description

Table 31: Hydros TA - Product Status

Table 32: Hydros TA - Product Description

Table 33: Hydros TA - Hip - Product Status

Table 34: Hydros TA - Hip - Product Description

Table 35: Carticept Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 36: Agilus - Product Status

Table 37: Agilus - Product Description

Table 38: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Table 39: Chi2Knee - Product Status

Table 40: Chi2Knee - Product Description

Table 41: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 42: Silk Hydrogel - Product Status

Table 43: Silk Hydrogel - Product Description

Table 44: DePuy Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 45: Platelet Rich Plasma System - Product Status

Table 46: Platelet Rich Plasma System - Product Description

Table 47: Flex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 48: Flex Polymer - Product Status

Table 49: Flex Polymer - Product Description

Table 50: Hanmi Pharmaceuticals, Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Table 51: Hyalrheuma - Product Status

Table 52: Hyalrheuma - Product Description

Table 53: Hanmi Pharmaceuticals, Co. Ltd. - Ongoing Clinical Trials Overview

Table 54: Hyalrheuma - Phase 3 Clinical Trial for Osteoarthritis Medicine Hyalrheuma

Table 55: Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 56: ArtiBest Intra-articular Injection - Product Status

Table 57: ArtiBest Intra-articular Injection - Product Description

Table 58: Moebius Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Table 59: MM-II - Product Status

Table 60: MM-II - Product Description

Table 61: Shanghai Haohai Biological Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Table 62: Thermal-Sensitive Chitosan Gel - Product Status

Table 63: Thermal-Sensitive Chitosan Gel - Product Description

Table 64: Spring Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

Table 65: CA-5136 - Product Status

Table 66: CA-5136 - Product Description

Table 67: Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview

Table 68: Arthrovisc - Product Status

Table 69: Arthrovisc - Product Description

Table 70: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

Table 71: 3-D Colloidal Gel - Product Status

Table 72: 3-D Colloidal Gel - Product Description

Table 73: Glossary

1.2 List of Figures

Figure 1: Viscosupplementation - Pipeline Products by Stage of Development

Figure 2: Viscosupplementation - Pipeline Products by Segment

Figure 3: Viscosupplementation - Pipeline Products by Territory

Figure 4: Viscosupplementation - Pipeline Products by Regulatory Path

Figure 5: Viscosupplementation - Pipeline Products by Estimated Approval Date

Figure 6: Viscosupplementation - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Anika Therapeutics, Inc.
BioPolymer GmbH & Co. KG
Bioventus LLC
Carbylan Therapeutics, Inc.
Carticept Medical, Inc.
Chi2Gel Ltd.
Cocoon Biotech, Inc.
DePuy Synthes, Inc.
Flex Biomedical, Inc.
Hanmi Pharmaceuticals, Co. Ltd.
Maxigen Biotech Inc.
Moebius Medical Ltd.
Shanghai Haohai Biological Technology Co., Ltd.
Spring Therapeutics
Synolyne Pharma
University of Kansas
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll